Introduction
Abstract
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract Dermatologists have long noted the need for a systemically administered drug designed to combat superficial infections of the skin due to fungi. Griseofulvin is the first such agent; its development appears to be assuming proportions of an historic nature. In October, 1959, the Department of Dermatology of the University of Miami School of Medicine,...